Opsona Therapeutics raises €18 million
Opsona Therapeutics, a Dublin, Ireland-based developer of therapeutic and preventative approaches to autoimmune and inflammatory diseases, has raised €18 million in Series B funding.
Capella Inc., a Galway, Ireland-based developer of medical devices to treat bifurcation vascular disease, has raised $17.3 million in Series C funding.